Plus: a diabetes drug may help reduce dementia; more
Tuesday, Oct. 13, 2020 : Issue #1071 DISASTERS AVERTED — Near Miss Case Studies
Best Plan for Patient May Not Be The Recommended Plan |
|
Letter from the Editor
This week we offer you part 3 of our series on the use of AI to select a proper diabetes medication regimen. Your response to the information has been overwhelming, and if the comments we have received are an indication of the desire to have this tool available, it only seems like a matter of time till the GlucosePATH software is available for everyone.
One feature that was commented on is the ability of the software to address comorbidities in selecting medication. This is very important when we look at patient disease states and multiple uses for a single medication.
This week Destiny Funchess, PharmD Candidate, South College School of Pharmacy, has a great article on how the use of a very common diabetes medication can possibly have an effect on reducing the risk of dementia.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief |
|
| |
|
|
|
DISASTERS AVERTED — Near Miss Case Studies |
|
| Best Plan for Patient May Not Be The Recommended Plan
Female, type 1 diabetes for 42 years, 58 years of age, lives with husband and dog. The patient has hypoglycemic unawareness. We regularly readjust her treatment plan and have recommended CGM for this patient on numerous occasions. Still, she refuses, stating her dog wakes her up if and when she has hypoglycemia. She called to let us know her dog passed away.... |
| |
|
|
SPECIAL FEATURE - AI & the Future of Diabetes Management |
|
| Part 3: Innovative Artificial Intelligence (AI) Tool Optimizes Care for T2D Patients
Optimize Clinical Diabetes Management with AI Technology
A new clinical software using artificial intelligence is being used for those with type 2 diabetes in Kentucky. It shows promising results in improving the Quality of Life for its residents and lowering treatment costs.
In part 3: user testimonials about the experience and exciting findings using the software. A more in-depth examination of the benefits of applying decision-support software in clinical practice. |
| |
|
|
TOP STORIES - Diabetes News and Research |
|
| |
|
|
|
| | | | About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control. |
| Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com |
|
|
|
|
| | |
|
|
|
|
